دورية أكاديمية
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
| العنوان: | Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials |
|---|---|
| المؤلفون: | Zhu, Andrew X., Nipp, Ryan D., Finn, Richard S., Galle, Peter R., Llovet, Josep M., Blanc, Jean-Frederic, Okusaka, Takuji, Chau, Ian, Cella, David, Girvan, Allicia, Gable, Jonathon, Bowman, Lee, Wang, Chunxiao, Hsu, Yanzhi, Abada, Paolo B., Kudo, Masatoshi |
| المساهمون: | Eli Lilly and Company |
| المصدر: | ESMO Open ; volume 5, issue 4, page e000797 ; ISSN 2059-7029 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1136/esmoopen-2020-000797 |
| الإتاحة: | https://doi.org/10.1136/esmoopen-2020-000797Test https://api.elsevier.com/content/article/PII:S2059702920326533?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2059702920326533?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc/4.0Test/ |
| رقم الانضمام: | edsbas.556E1036 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/esmoopen-2020-000797 |
|---|